Respiratory Care Devices Market Expected To Reach USD 37.04 Billion By 2027 | Key Players: Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland) and Others

April 06 20:45 2021
Respiratory Care Devices Market Expected To Reach USD 37.04 Billion By 2027 | Key Players: Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland) and Others

Reports And Data
The rise in the incidence of respiratory disorders, adaptation to new technological advances, new product launches, and strategic collaboration, rise in the patient pool are key factors contributing to the high CAGR of the Respiratory Care Devices market during the forecast period. Respiratory Care Devices Market Size – USD 18.41 Billion in 2019, Market Growth – CAGR of 9.0% Market Trends– Favorable regulatory policies.

According to the current analysis of Reports and Data, the global Respiratory Care Devices Market valued at USD 18.41 Billion in 2019 and is expected to reach USD 37.04 billion by the year 2027, at a CAGR of 9.0%. Respiratory care devices are increasingly used in the treatment, monitoring, and diagnosis of respiratory disorders. These devices are given to the patients to improve the treatment process.

The rise in lifestyle habits like smoking, consumption of alcohol, and an increase in the geriatric population is a significant factor boosting the market. Technological advances for new devices, regulatory approvals, product launches are further promoting market growth. The prevalence of air pollution, climate changes, dust, are also fueling the market growth. The rising prevalence of Respiratory diseases is snowballing all over the world. In 2017, according to the WHO, Respiratory diseases were considered to be the leading causes of death and disability in the world. Nearly 65 million people suffer from chronic obstructive pulmonary disease (COPD), and 3 million are expected to die from it each year, making it the third leading cause of death across the world. Moreover, approximately 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14% of all children globally.

The COVID-19 Impact: As the spread of Coronavirus (COVID-19) persists throughout the global community, the key market players are supporting the health systems and healthcare professionals actively. For instance, Phillips is providing solutions including invasive and non-invasive ventilation ranging from mid- to high-acuity, oxygen therapy, CPAP therapy, nebulizers, patient monitoring, medical consumable, and others. Moreover, the limited supply of ventilators is one of the chief concerns faced by hospitals and other healthcare facilities. To overcome the situation, In the U.S., emergency plans have been developed by states for a shortage of ventilators include using positive airway pressure machines. It is used to sleep apnea which would help hospitalized people with less severe breathing issues.

Additionally, with proper preventive and improving the quality of air, most respiratory diseases are preventable. Common sources of unhealthy air are tobacco smoke, indoor and outdoor air pollution, and air containing microbes, toxic particles, fumes, or allergens are contributing factors to the rising demand of the respiratory care devices market. According to the WHO, At least 2 billion people are exposed to indoor toxic smoke, 1 billion inhale outdoor pollutant air, and 1 billion are exposed to tobacco smoke. The rising geriatric population is a major cause of driving the market in countries like China and India. According to the World Health Organization (WHO), more than 2 billion population will be aged 60 and older by 2050. The increasing patient pool and adoption of an unhealthy lifestyle, including smoking and consumption of alcohol in the developed economy, is likely to boost the market in the near future. However, the lack of awareness among the public about devices, some of the harmful effects of respiratory devices on neonates, and inefficient reimbursement are the factors hindering the market growth.

Get a Sample Copy of This [email protected]

Further key findings from the report suggest

  • In the year 2018, Convexity Scientificlaunched its Flyp nebulizer for COPD and asthma patients it is a held handheld, the pocket-sized device was approved by the FDA in the year 2017. Convexity’s nebulizer comprises an internal vibrating disk that produces an inhaled aerosol mist to deliver medication deep into patients’ lungs.
  • CAIRE, in the year 2019, launched FreeStyle, it is a portable oxygen concentrator. It is being designed to deliver oxygen bolus as the user’s respiratory rate. FreeStyle Comfort is designed to be comfortable for wear due to its unique ergonomic design. It has also met FAA guidelines for use on commercial air flights and also offers wireless connectivity.
  • Masimo, in the year 2017, received an FDA 510(k) clearance for Rad-97 pulse co-oximeter and had launched it in the US. Rad-97 consists of a multi-touch display, a small footprint, and easy configuration; it also comprises of WiFi and supported Bluetooth wireless connections to related compatible devices like thermometers, glucometers, and weight scales.
  • Medtronic in the year 2019, announced the complete acquisition with Klue. Klue’s technology is expected include the Medtronic Personalized Closed Loop (PCL) insulin pump system. Klue’s has a unique early meal detection technology that can help in transforming diabetes care; this is expected to be a huge opportunity for Medtronic in diabetes care.
  • The key players in the respiratory care devices market are Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Chart Industries (US), Drager AG (Germany), Invacare Corporation (US), Getinge AB (Sweden), Air Liquide (France), Hamilton Medical AG (Switzerland), Vyaire Medical (US), GE Healthcare (US), Nonin Medical Inc. (US), Apex Medical Corp. (Taiwan), Smiths Group (UK), Omron Healthcare Inc. (US), Allied Healthcare Products, Inc. (US), Teleflex Incorporated (US), DeVilbiss Healthcare LLC (US), Convexity Scientific (US), CAIRE (US), Oventus Medical’s (Australia)

Buy Now:

For the purpose of this purpose, Reports and Data have segmented the Respiratory Care Devices market on the basis of products, indications, end use, and region

Products Outlook (Revenue in Million USD; 2017–2027)

  • Therapeutic Devices
    • PAP Devices
    • Ventilators
    • Nebulizers
    • Humidifiers
    • Oxygen Concentrators
    • Inhalers
    • Reusable Resuscitators
  • Monitoring Devices
    • Pulse Oximeters
      • Pulse oximeter sensors
      • Pulse Oximeter equipment
    • Capnographs
    • Gas Analyzers
  • Diagnostic Devices
    • Spirometers
    • Polysomnography Devices
    • Peak Flow Meters
    • Other Diagnostic Devices
  • Consumables and Accessories
    • Masks
      • Reusable Masks
      • Nasal Masks
      • Full-face Masks
      • Nasal pillow masks
      • Oral Masks
      • Disposable Masks
    • Disposable Resuscitators
    • Breathing Circuits
    • Tracheostomy Tubes
    • Nasal Cannulas
    • Others

Indications Outlook (Revenue in Million USD; 2017–2027)

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Infectious Disease
  • Lung Cancer
  • Tuberculosis
  • Idiopathic Pulmonary Fibrosis

End Use Outlook (Revenue in Million USD; 2017–2027)

  • Hospitals
  • Home Care Settings
  • Ambulatory Care Centers

Regional Outlook (Revenue in Million USD; 2017–2027)

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

To identify the key trends in the industry, click on the link below:

 Table of Content:

Chapter 1. Market Synopsis

    1.1. Market Definition

    1.2. Research Scope & Premise

    1.3. Methodology

    1.4. Market Estimation Distribution Channel

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2017 & 2027

Chapter 3. Indicative Metrics

    3.1. Macro-Economic Indicators

          3.1.1. Advancements in Technology

          3.1.2. Government funding for research and development

Chapter 4. COVID 19 impact assessment

    4.1. Healthcare Personal Protective Equipment Industry Outlook
 Q1 2020
 Q2 2020
 Q3 2020

    4.2. Rising demand for Personal Protective Equipment due to COVID 19 pandemic Crisis

    4.3. Supply chain stabilization

   Supply scenario

   Demand scenario

    4.4. Upcoming strategies required to combat the current situation

    4.5. Alternative availability for suppliers

    4.6. No-contact methodologies in the supply chain

    4.7. Customer mapping

Chapter 5. Global Respiratory Care Devices Market Segmentation & Impact Analysis

    5.1. Global Respiratory Care Devices Market Segmentation Analysis

    5.2. Industrial Outlook

    5.3. Market Indicators Analysis

          5.3.1. Market Drivers Analysis

          Rise in the prevalence of respiratory disorders

          Rise in the geriatric population

          5.3.2. Market Restraints Analysis

          High expenditure cost of therapy

    5.4. Regulatory Framework

    5.5. Porter’s Five Forces Analysis

Chapter 6. Global Respiratory Care Devices Market by Products Insights & Trends

   6.1. Respiratory Care Devices Market Products Dynamics & Market Share, 2020 & 2027

   6.2. Therapeutic Devices

          6.2.1. Market estimates and forecast, 2017 & 2027 (USD Million)

          6.2.2. Market estimates and forecast, by region, 2017 & 2027 (USD Million)

          6.2.3. PAP Devices

Chapter 10. Competitive Landscape
    10.1. Market Revenue Share by Manufacturers
    10.2. Mergers & Acquisitions
    10.3. Strategy Benchmarking
             10.3.1. Partnership & Agreement
             10.3.2. New Products Development
             10.3.3. Mergers & Acquisitions
             10.3.4. Investment & Expansion
    10.4. Vendor Landscape
Chapter 11. Company Profiles
    11.1. Philips Healthcare
            11.1.1. Company Overview
            11.1.2. Financial Insights
            11.1.3. Products Offered
            11.1.4. Strategic Initiatives
 11.2. ResMed Inc.
            11.2.1. Company Overview
            11.2.2. Financial Insights
            11.2.3. Products Offered
            11.2.4. Strategic Initiatives
    11.3. Medtronic plc
           11.3.1. Company Overview
           11.3.2. Financial Insights
           11.3.3. Products Offered
           11.3.4. Strategic Initiatives
    11.4. Masimo Corporation
           11.4.1. Company Overview
           11.4.2. Financial Insights
           11.4.3. Products Offered
           11.4.4. Strategic Initiatives
    11.5. Fisher & Paykel Healthcare Corporation Limited
            11.5.1. Company Overview
            11.5.2. Financial Insights
            11.5.3. Products Offered
            11.5.4. Strategic Initiatives
    11.6. Chart Industries
            11.6.1. Company Overview
            11.6.2. Financial Insights
            11.6.3. Products Offered
            11.6.4. Strategic Initiatives


About Us:

Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States

Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/ on line 7